Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of the combination of Etanercept and Docetaxel in
patients with advanced solid tumors for which there is no standard treatment.